Love begins with yourself: Thrive Newsletter - Faculty Wellness - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/about-us/faculty-wellness/archives/thrive/love-yourself.html
Often, it’s associated with romance, passion, and grand gestures to the person who makes our heart go a-thumpin’. Little do we realize that for the world to truly go ‘round, love begins with oneself (or it should, anyway).” -- Tatiana Azman
Relationships are everything : Thrive Newsletter - Faculty Wellness - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/about-us/faculty-wellness/archives/thrive/relationships.html
Relationships are at the heart of everything we do at UT Southwestern. In fact, we can see UT Southwestern Medical Center as nothing more than a rich and complex set of relationships among a diverse collection of people.
akin-ayodele-bio.pdf
https://www.utsouthwestern.edu/about-us/faculty-wellness/events/symposium/akin-ayodele-bio.pdf
An entrepreneur at heart, Akin was Managing Partner and Co-Founder of Eagle Rock Wealth Management before joining Sapoznik Insurance a World Insurance Company.
Mission & History: 1960-1979 - UT Southwestern Medical Center, Dallas, TX
https://www.utsouthwestern.edu/about-us/mission-history/1960-1979.html
With broad faculty support, he launched a $50 million building project; $8 million came from philanthropic funds raised by the Southwestern Medical Foundation , including major contributions from the founders of Texas Instruments: Eugene McDermott, Erik Jonsson, and Cecil Green.
Texas Impact - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/about-us/texas-impact/
Published from Research Biomarker blood test could reveal high risk heart patients in need of treatment (With Video) A new blood test for protein biomarkers could identify high risk heart patients.
2023-2024 Disbursement Calendar - Financial Aid Office - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/about-us/administrative-offices/financial-aid/disbursement-calendar/
Term Start Date Summer 2023 05/05/2023 05/10/2023 05/15/2023 Fall 2023 08/11/2023 08/16/2023 08/21/2023 Spring 2024 12/29/2023 01/03/2024 01/08/2024 Medical School Fall 2023 Grade Level Disbursement to the School Refund Available to Student (After Tuition/Fees Deduction) Term Start Date MS1 07
September 2022 PO Transparency Report - UT Southwestern
https://www.utsouthwestern.edu/about-us/administrative-offices/purchasing/po-transparency/202209_PO_Transparency_Report.pdf
Competitive Procurement Req 5230002767 2022-09-07 2022-09-07 POSSIBLE MISSIONS INC Inorganic compounds 33.71 No Competitive Procurement Req 5230002768 2022-09-07 2022-09-07 POSSIBLE MISSIONS INC Biochemicals 554.91 No Competitive Procurement Req 5230002769 2022-09-07 2022-09-07 SIGMA-ALDRICH INC
202210_PO_Transparency_Report.pdf
https://www.utsouthwestern.edu/about-us/administrative-offices/purchasing/po-transparency/202210_PO_Transparency_Report.pdf
2022-10-07 2022-10-07 TORNIER INC Surgical bone cements 7100.2 Catalog 5230021717 2022-10-07 2022-10-07 SMITH & NEPHEW ORTHOPAEDIC ENT DIVISON Bone screws 4486.49 Catalog 5230021718 2022-10-07 2022-10-07 POSSIBLE MISSIONS INC Antibodies 186 No Competitive Procurement Req 5230021719 2022-10-07 2022
Discover: 2022 Year in Review - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/about-us/year-in-review/2022/discover/
More Info International team solves longtime structure mystery A study published in Nature Structural & Molecular Biology is the first to solve and model virtually the entire structure of seipin , a transmembrane protein essential for proper fat storage. The study by Joel M.
202211_Contract_Transparency%20Report.pdf
https://www.utsouthwestern.edu/about-us/administrative-offices/purchasing/contract-transparency/202211_Contract_Transparency%20Report.pdf
Contract Transparency Report November 2022 Contract Number Amendment Number Contract Type Second Party Starts On Ends On Status Title P O Number PO Type Payable Total Approved On FY2023-12768 0 Purchasing Agreement Time-Out Media 11/07/22 02/19/23 Executed in Effect STU102017-068 A Neurosteroid